Previous close | 14.40 |
Open | N/A |
Bid | 14.00 |
Ask | 24.00 |
Strike | 175.00 |
Expiry date | 2026-12-18 |
Day's range | 14.40 - 14.40 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...